Treatment of Advanced Metastatic Melanoma

The introduction in clinical practice of new drug compounds both targeted therapies anti-BRAF and checkpoint inhibitors have largely improved our potential to manage advanced metastatic melanoma patients. This has led to a significant improvement in terms of response rates and particularly in the o...

Full description

Saved in:
Bibliographic Details
Main Authors: Pietro Quaglino, Paolo Fava, Luca Tonella, Marco Rubatto, Simone Ribero, Maria Teresa Ferro
Format: article
Language:EN
Published: Mattioli1885 2021
Subjects:
Online Access:https://doaj.org/article/fc9ee1c4f4f647f099d8873a21b3f64b
Tags: Add Tag
No Tags, Be the first to tag this record!